The expression of CCL5 and its receptor CCR5 has been found to be elevated in many tumors, including triple-negative breast cancer [38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53]. This evidence concerns the gene CCL5 and triple-negative breast carcinoma.